CSNK1A1 and neoplasm: Tumor cell growth studies with CKIA (every 24 hours treatment) indicated a significantly reduced cell proliferation in all tumor cell lines at 48 and 72 hours after treatment with 0.1 (<50%) and 1 μM (<25%) of CKIA (Figure 1, P < .05).